Please contact our sales representative to learn more information about this reagents.
Background
Ertumaxomab (trade name Rexomun) is a rat-murine hybrid monoclonal antibody designed to treat some types of cancer. It is a trifunctional antibody which works by linking T-lymphoFlow Cytes and macrophages to the cancer cells.